We report here on the successful use of functionalized nanohydrogels for the targeted delivery of siRNA against EGFR (epidermal growth factor receptor) in an ovarian cancer mouse model and the consequent inhibition of tumor growth and enhancement of cisplatin chemotherapy. Here, EGFR is linked to neoplasm.